ArticleCancers2025

Upstaging of Patients Diagnosed with Favorable Intermediate-Risk Prostate Cancer-Is Active Surveillance Really a Suitable Approach for All These Patients?

Analena E Handke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.